Clinical Trial Update: Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating LO2A eye drops for moderate to severe conjunctivochalasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivochalasis

Drugs mentioned

• LO2A Eye Drops

Snippet

Sponsor: Ocuwize LTD | Conditions: Conjunctivochalasis | Phase 2 | Status: COMPLETED